Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NMDP BioTherapies does not develop its own clinical-stage products but enables the development and delivery of autologous and allogeneic cellular therapies through comprehensive sourcing, logistics, regulatory support, collection network management, and long-term follow-up tracking. It has supported more than sixty companies in advancing their programs to market. Through its parent organization’s history (>35 years), it has impacted over 130,000 lives via cell therapies. It supports FDA-approved CAR-T programs with long-term follow-up data collection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NMDP BioTherapies.